Keywords
Headache
Intracranial Sinus Thromboses
Stroke
SARS-CoV-2
Categories
How to Cite
Abstract
Abstract
SARS-CoV-2 infection responsible for COVID-19, has demonstrated neurotropic and neuroinvasive potential, displaying several neurological manifestations ranging from mild to severe complications, the latter related to a prothrombotic state, giving place to stroke and less often cerebral venous thrombosis. The physiopathology of these events is currently elucidated from various mechanisms including thrombo-inflammation, endotheliopathy, and stasis in critically ill patients.
Cerebral venous thrombosis is a possible complication of COVID-19 in any stage, even in patients with a non-severe course of the disease; the mechanism involved is probably related to microcirculatory dysfunction enhanced by prothrombotic comorbid conditions.
References
Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26(7):1017-32. doi: 10.1038/s41591-020-0968-3
Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020; 77(6):683-690. doi: 10.1001/jamaneurol.2020.1127
Han H, Yang L, Liu R, Liu F, Wu KL, Li J, et al. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med. 2020;58(7):1116-20. doi: 10.1515/cclm-2020-0188
Bhatia R, Srivastava MVP. COVID-19 and Stroke: Incidental, Triggered or Causative. Ann Indian Acad Neurol. 2020;23(3):318-24. doi: 10.4103/aian.AIAN_380_20.
Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020;135(23):2033-40. doi: 10.1182/blood.2020006000
Al-Samkari H, Karp Leaf RS, Dzik WH, Carlson JC, Fogerty AE, Waheed A, et al. COVID and Coagulation: Bleeding and Thrombotic Manifestations of SARS-CoV2 Infection. Blood. 2020;135(23):2033-2040. doi: 10.1182/blood.2020006000
Shi W, Lv J, Lin L. Coagulopathy in COVID-19: Focus on vascular thrombotic events. J Mol Cell Cardiol. 2020;146:32-40. doi: 10.1016/j.yjmcc.2020.07.003
Li Y, Li M, Wang M, Zhou Y, Chang J, Xian Y, et al. Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. Stroke Vasc Neurol. 2020;5(3):279-284. doi: 10.1136/svn-2020-000431
Sweid A, Hammoud B, Bekelis K, Missios S, Tjoumakaris SI, Gooch MR, et al. Cerebral ischemic and hemorrhagic complications of coronavirus disease 2019. Int J Stroke. 2020;15(7):733-742. doi: 10.1177/1747493020937189
Hughes C, Nichols T, Pike M, Subbe C, Elghenzai S. Cerebral Venous Sinus Thrombosis as a Presentation of COVID-19. Eur J Case Rep Intern Med. 2020;7(5):001691. doi: 10.12890/2020_001691
Garaci F, Di Giuliano F, Picchi E, Da Ros V, Floris R. Venous cerebral thrombosis in COVID-19 patient. J Neurol Sci. 2020;414:116871. doi: 10.1016/j.jns.2020.116871
Hemasian H, Ansari B. First case of Covid-19 presented with cerebral venous thrombosis: A rare and dreaded case. Rev Neurol (Paris). 2020;176(6):521-523. doi: 10.1016/j.neurol.2020.04.013
Poillon G, Obadia M, Perrin M, Savatovsky J, Lecler A. Cerebral venous thrombosis associated with COVID-19 infection: Causality or coincidence? J Neuroradiol. 2020;S0150-9861(20)30167-X. doi: 10.1016/j.neurad.2020.05.003
Dahl-Cruz F, Guevara-Dalrymple N, López-Hernández N. [Cerebral venous thrombosis and SARS-CoV-2 infection]. Rev Neurol. 2020;70(10):391-392. doi: 10.33588/rn.7010.2020204
Klein DE, Libman R, Kirsch C, Arora R. Cerebral venous thrombosis: A typical presentation of COVID-19 in the young. J Stroke Cerebrovasc Dis. 2020;29(8):104989. doi: 10.1016/j.jstrokecerebrovasdis.2020.104989
Malentacchi M, Gned D, Angelino V, Demichelis S, Perboni A, Veltri A, et al. Concomitant brain arterial and venous thrombosis in a COVID-19 patient. Eur J Neurol. 2020; 10.1111/ene.14380. doi: 10.1111/ene.14380
Chougar L, Mathon B, Weiss N, Degos V, Shor N. Atypical Deep Cerebral Vein Thrombosis with Hemorrhagic Venous Infarction in a Patient Positive for COVID-19. AJNR Am J Neuroradiol. 2020;41(8):1377-79. doi: 10.3174/ajnr.A6642
Cavalcanti DD, Raz E, Shapiro M, Dehkharghani S, Yaghi S, Lillemoe K, et al. Cerebral Venous Thrombosis Associated with COVID-19. AJNR Am J Neuroradiol. 2020;41(8):1370-76. doi: 10.3174/ajnr.A6644
Baudar C, Duprez T, Kassab A, Miller N, Rutgers MP. COVID-19 as triggering co-factor for cortical cerebral venous thrombosis? J Neuroradiol. 2020;S0150-9861(20)30205-4. doi: 10.1016/j.neurad.2020.06.008
Roy-Gash F, De Mesmay M, Devys JM, Vespignani H, Blanc R, Engrand N. COVID-19-associated acute cerebral venous thrombosis: clinical, CT, MRI and EEG features. Crit Care. 2020;24(1):419. doi: 10.1186/s13054-020-03131-x
Bolaji P, Kukoyi B, Ahmad N, Wharton C. Extensive cerebral venous sinus thrombosis: a potential complication in a patient with COVID-19 disease. BMJ Case Rep. 2020;13(8):e236820. doi: 10.1136/bcr-2020-236820
Saposnik G, Barinagarrementeria F, Brown RD, Bushnell CD, Cucchiara B, Cushman M, et al. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42(4):1158-92. doi: 10.1161/STR.0b013e31820a8364
Abou-Ismail MY, Diamond A, Kapoor S, Arafah Y, Nayak L. The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management. Thrombosis Research. 2020;194:101-115. doi: 10.1016/j.thromres.2020.06.029
Atallah B, Mallah SI, AlMahmeed W. Anticoagulation in COVID-19. Eur Heart J Cardiovasc Pharmacother. 2020;6(4):260-261. doi: 10.1093/ehjcvp/pvaa036
Mummery RS, Rider CC. Characterization of the heparin-binding properties of IL-6. J Immunol. 2000 ;165(10):5671-9. doi: 10.4049/jimmunol.165.10.5671
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2021 Ictus